COVID-19 pandemic led to stark rise in depressive and anxiety disorders globally in 2020, with women and younger people most affected.

First global estimates of impact of the COVID-19 pandemic on mental health in 2020 suggests additional 53 million cases of major depressive disorder and 76 million cases of anxiety disorders were due to the pandemic. Women and younger people were the most affected by major depressive disorder and anxiety disorders in 2020. Countries hit hardest…

Treatment of COVID-19 with fluvoxamine reduces risk of prolonged hospitalisation, finds largest trial to date

The fluvoxamine arm of the TOGETHER trial, a randomised adaptive platform trial investigating the efficacy of repurposed treatments for COVID-19 among high-risk Brazilian adult outpatients, is the largest trial of the SSRI fluvoxamine as a COVID-19 treatment to date. Of the 741 participants who were treated in an emergency setting for COVID-19 after receiving fluvoxamine,…

COVID-19 vaccines lower risk of infection with delta variant, but infection can still be passed on in household settings

Study of 621 people in the UK with mild COVID-19 infections found that people who received two vaccine doses could still pass the infection on to vaccinated and unvaccinated household members. The analysis found that 25% of vaccinated household contacts tested positive for COVID-19 compared with 38% of unvaccinated household contacts. The infectiousness of vaccinated…